PRF Technologies Ltd.
Business
PAINREFORM LTD. is a specialty pharmaceutical and technology company focused on reformulating established therapeutics and delivering AI-driven solar analytics. It develops PRF-110, a proprietary extended‑release, oil‑based ropivacaine formulation for localized post‑surgical analgesia, and offers DeepSolar, an AI-powered software platform (MyDeepSolar) for PV system monitoring and optimization. The company operates two principal divisions: drug development (clinical trials, regulatory filings, manufacturing via CMOs) and DeepSolar software services. It sells through clinical and surgical channels, hospitals, ambulatory centers and via B2B and B2B2C routes to solar operators and homeowners in the U.S., Europe and other international markets.
Summary from filing dated 2025-04-07
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $17.0K |
| Net income | $-5.02M |
| Total assets | $12.00M |
| Total liabilities | $2.71M |
| Stockholders' equity | $8.54M |
| Operating cash flow | $-3.96M |